associated with AUD symptom count, FH was significantly associated (positive vs. negative: β [SE] = .327 [.125], p = .009); therefore, GEE analyses controlled for FH by including two dummy variables (FH positive vs. negative, FH unsure vs. negative). The analyses also controlled for BrAC given the variability in levels from oral alcohol administration. The false discovery rate method was used to correct p values for multiple comparisons (39).
